Keyword: Shire

News

Takeda to Move US Headquarters to Boston

14.09.2018 - Following the completion of its $64 billion takeover of Shire, Japanese drugmaker Takeda has announced plans to restructure its US operations. In a first move, it will close its...

News

Shire sells Oncology Portfolio to Servier

04.09.2018 - Ahead of its acquisition by Japan’s Takeda Pharmaceutical, Ireland-domiciled, London-listed and US-focused Shire has completed the sale of its oncology portfolio with $262 million...

News

US FTC Clears Takeda’s Shire Buy

11.07.2018 - On its path to acquiring Ireland-domiciled, London-listed drugmaker Shire, Japan’s Takeda Pharmaceutical has received unconditional clearance from the US Federal Trade Commission...

News

Takeda and Shire Agree Merger Terms

09.05.2018 - Takeda Pharmaceutical and Shire have finally agreed terms for a merger, ending a takeover battle that has seen the Japanese drugmaker bid five times since late March for the...

News

Shire Agrees Takeda Takeover Bid

26.04.2018 - Shire has announced that it would be willing to recommend Takeda’s latest and fifth proposal to its shareholders. The revised offer, Takeda’s fifth in recent weeks, values Shire at...

News

Takeda Ups Bid for Shire

24.04.2018 - Japanese drugmaker Takeda has hiked its bid for Shire, also increasing the cash part of the deal. In its latest proposal, made on Apr. 20, Takeda has offered £47 per share, valuing...

News

Shire Sells Oncology Unit to Servier for $2.4 Billion

18.04.2018 - Ireland-based drugs giant Shire is selling its oncology business to France’s Servier in a deal worth $2.4 billion. The sale comes just as Japan’s Takeda Pharmaceutical was reported...

News

Takeda Mulls Bid for Shire

04.04.2018 - Japanese drugmaker Takeda has announced that it is considering buying Ireland-domiciled drugmaker Shire, although it stressed that the offer was “at a preliminary and exploratory...